Notably, AT1R transactivates EGFR in several cancers [37], leading to extracellular-regulated kinase (ERK) activation, phosphorylation of signal transducer and activator of transcription 3 (STAT3) and activation of protein kinase C (PKC). Here, PRRT2 is linked to cancer.